 |
|
|
| |
PREVALENCE AND IMPACT OF PRETREATMENT DRUG RESISTANCE IN 12249 TREATMENT AS PREVENTION TRIAL
|
| |
| |
Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
Anne Derache1,2, Collins Iwuji2, Siva Danaviah1, Kathy Baisley3, Anne-Genevieve Marcelin4, Vincent Calvez4, Tulio De Oliveira5, Kholoud Porter2, Francois Dabis6 and Deenan Pillay1 for the ANRS 12249 team
Underlined authors equally contributed to the work presented below
1Africa Health Research Institute, KwaZulu-Natal, South Africa, 2University College London, London, United Kingdom, 3London School of Hygiene and Tropical Medicine, London, United Kingdom, 4Pitie-Salpetriere Hospital, Paris, France, 5University of KwaZulu-Natal, Durban, South Africa, 6Université de Bordeaux, ISPED, Centre INSERM 1219, Bordeaux France
The impact of Universal Test and Treat on HIV incidence in a rural South African population ....Poor Linkage to Care Undermines Test-and-Treat in South African Trial....http://www.natap.org/2016/IAC/IAC_63.htm
|
| |
|
|
|
|
|
